{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031918","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2026-07-02T20:30:31+00:00","discovered_at":"2026-07-02T20:32:01.191204+00:00","generated_at":"2026-07-02T20:32:27.863950+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Hepion Pharmaceuticals appoints Danina Fisher and Gary S. Stetz, II to board","bullets":["Danina Fisher and Gary S. Stetz, II appointed as directors effective July 1, 2026.","Gary S. Stetz, II is the son of Gary Stetz, the Interim CEO.","No arrangements or understandings with any other person regarding their selection as directors.","No family relationships exist between the new directors except the father-son relationship noted."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031918","json":"https://secwatch.observer/filing/0001493152-26-031918.json","markdown":"https://secwatch.observer/filing/0001493152-26-031918.md","text":"https://secwatch.observer/filing/0001493152-26-031918.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226031918/0001493152-26-031918-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226031918/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:32:27.863950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}